 AstraZeneca PLC LSE:AZN has succeeded in stopping a former senior executive from joining rival GSK PLC LSE:GSK, NYSE:GSK via an injunction granted by a High Court judge. Having recently left AstraZeneca after holding several senior positions, Chris Sheldon was due to join GSK on September 1, in charge of developing the groups therapy businesses. 